HUP9901911A1 - Orfanin FQ (OFQ) receptor agonista és/vagy antagonista diaza-spiro[3,5]nonán-származékok, előállításuk és alkalmazásuk - Google Patents
Orfanin FQ (OFQ) receptor agonista és/vagy antagonista diaza-spiro[3,5]nonán-származékok, előállításuk és alkalmazásukInfo
- Publication number
- HUP9901911A1 HUP9901911A1 HU9901911A HUP9901911A HUP9901911A1 HU P9901911 A1 HUP9901911 A1 HU P9901911A1 HU 9901911 A HU9901911 A HU 9901911A HU P9901911 A HUP9901911 A HU P9901911A HU P9901911 A1 HUP9901911 A1 HU P9901911A1
- Authority
- HU
- Hungary
- Prior art keywords
- alkyl
- hydrogen atom
- ofq
- orphanin
- diaza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
A találmány szerinti vegyületek (I) általánős képletében R1 jelentése adőtt esetben alkil- vagy -C(O)O- alkil-csőpőrttalhelyettesített 6-12 szénatőmős ciklőalkilcsőpőrt, adőtt esetbenalkilcső-pőrttal helyettesített indan-1-il- vagy indan-2-il-csőpőrt,acenaften-1-il-, beciklő[3.3.1]nőn-9-il-. őktahidrőinden-2-il-, 2,3-dihidrő-1H-fenalen-1-il-, 2,3,3a,4,5,6-hexahidrő-1-H-fenalen-1-il-,dekahidrőazűlen-2-il-, biciklő[6.2.0]dec-9-il-. dekahidrőnaftalin-1-il-, dekahidrőnaftalin-2-il-, tetrahidrőnaftalin-2-il- vagy 2-őxő-1,2-difenil-etil-csőpőrt, R2 jelentése =O vagy hidrőgénatőmők, R3 jelentése hidrőgénatőm, 1,3-diőxőizőindőlil-, alkőxi-, alkil-,aminő-, benzil-őxi-, -CH2OR5 vagy -CH2N(R5)2 csőpőrt, R4 jelentése hidrőgénatőm vagy -CH2OR5, R5 jelentése hidrőgénatőm vagy alkilcsőpőrt, A jelentése adőtt esetben alkil-, halőgén- vagy alkőxihelyettesítőthőrdőzó ciklőhexil- vagy fenilcsőpőrt. A találmány magában főglalja avegyületek racém keverékei és a megfelelő enantiőmereit és/vagy evegyületek gyógyászatilag alkalmas savaddíciós sóit is. (I) ŕ
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98110804 | 1998-06-12 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9901911D0 HU9901911D0 (en) | 1999-08-30 |
| HUP9901911A1 true HUP9901911A1 (hu) | 2000-05-28 |
| HU220894B1 HU220894B1 (en) | 2002-06-29 |
Family
ID=8232114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901911A HU220894B1 (en) | 1998-06-12 | 1999-06-09 | Orphanin fq (ofq) receptor agonist and/or antagonist diaza-spiro[3,5]nonane derivatives, preparation and use thereof |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6113527A (hu) |
| EP (1) | EP0970957B1 (hu) |
| JP (1) | JP3286268B2 (hu) |
| KR (1) | KR100344732B1 (hu) |
| CN (1) | CN1107066C (hu) |
| AR (1) | AR019859A1 (hu) |
| AT (1) | ATE204279T1 (hu) |
| AU (1) | AU743983B2 (hu) |
| BR (1) | BR9902651A (hu) |
| CA (1) | CA2274202A1 (hu) |
| DE (1) | DE69900220T2 (hu) |
| DK (1) | DK0970957T3 (hu) |
| ES (1) | ES2162503T3 (hu) |
| HR (1) | HRP990188A2 (hu) |
| HU (1) | HU220894B1 (hu) |
| ID (1) | ID23304A (hu) |
| IL (1) | IL130377A0 (hu) |
| MA (1) | MA26644A1 (hu) |
| NO (1) | NO312590B1 (hu) |
| NZ (1) | NZ336189A (hu) |
| PE (1) | PE20000548A1 (hu) |
| PL (1) | PL333695A1 (hu) |
| PT (1) | PT970957E (hu) |
| SG (1) | SG79259A1 (hu) |
| SI (1) | SI0970957T1 (hu) |
| TR (1) | TR199901381A3 (hu) |
| YU (1) | YU26499A (hu) |
| ZA (1) | ZA993852B (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003004034A1 (en) * | 2001-07-02 | 2003-01-16 | Omeros Corporation | Method for inducing analgesia comprising administration alternatively of an opioid receptor agonist and an opioid receptor like receptor 1 agonist for and an implantable infusion pump |
| US20030040479A1 (en) * | 2001-07-02 | 2003-02-27 | Omeros Corporation | Rotational intrathecal analgesia method and device |
| DK1491212T3 (da) * | 2002-03-29 | 2012-10-29 | Mitsubishi Tanabe Pharma Corp | Middel til behandling af søvnforstyrrelser |
| JP2005289816A (ja) | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
| MXPA05000370A (es) * | 2002-07-05 | 2005-04-19 | Targacept Inc | Compuestos n-aril diazaespiraciclicos y metodos de preparacion y usos de los mismos. |
| EP1601674B1 (en) * | 2002-09-09 | 2012-08-08 | Janssen Pharmaceutica NV | Hydroxyalkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| GB0323204D0 (en) * | 2003-10-03 | 2003-11-05 | Novartis Ag | Organic compounds |
| US20050228023A1 (en) * | 2003-12-19 | 2005-10-13 | Sri International | Agonist and antagonist ligands of the nociceptin receptor |
| US20060178390A1 (en) * | 2004-08-02 | 2006-08-10 | Alfonzo Jordan | 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| CA2575461A1 (en) * | 2004-08-20 | 2006-03-02 | Targacept, Inc. | The use of n-aryl diazaspiracyclic compounds in the treatment of addiction |
| US20080247964A1 (en) * | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
| CN101622254B (zh) * | 2006-11-28 | 2013-05-29 | 詹森药业有限公司 | 3-(3-氨基-2-(r)-羟基-丙基)-1-(4-氟-苯基)-8-(8-甲基-萘-1-基甲基)-1,3,8-三氮杂-螺[4.5]癸烷-4-酮的盐 |
| CN101679430B (zh) * | 2007-04-09 | 2013-12-25 | 詹森药业有限公司 | 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物 |
| KR101704226B1 (ko) | 2015-06-30 | 2017-02-07 | 현대자동차주식회사 | 자동차의 쿼터글라스 어셈블리 |
| MX2024007780A (es) * | 2021-12-22 | 2024-09-11 | Univ California | Inhibidores de unión covalente de mutantes g12s, g12d y/o g12e de k-ras gtpasa. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756743A (en) * | 1996-04-10 | 1998-05-26 | Hoechst Marion Roussel Inc. | Spiro cyclopent b!indole-piperidines! |
-
1999
- 1999-06-07 DK DK99110943T patent/DK0970957T3/da active
- 1999-06-07 EP EP99110943A patent/EP0970957B1/en not_active Expired - Lifetime
- 1999-06-07 ES ES99110943T patent/ES2162503T3/es not_active Expired - Lifetime
- 1999-06-07 PT PT99110943T patent/PT970957E/pt unknown
- 1999-06-07 DE DE69900220T patent/DE69900220T2/de not_active Expired - Lifetime
- 1999-06-07 SI SI9930008T patent/SI0970957T1/xx unknown
- 1999-06-07 AT AT99110943T patent/ATE204279T1/de not_active IP Right Cessation
- 1999-06-08 ZA ZA9903852A patent/ZA993852B/xx unknown
- 1999-06-08 PE PE1999000487A patent/PE20000548A1/es not_active Application Discontinuation
- 1999-06-08 ID IDP990543D patent/ID23304A/id unknown
- 1999-06-09 IL IL13037799A patent/IL130377A0/xx unknown
- 1999-06-09 CA CA002274202A patent/CA2274202A1/en not_active Abandoned
- 1999-06-09 NZ NZ336189A patent/NZ336189A/xx unknown
- 1999-06-09 SG SG9903066A patent/SG79259A1/en unknown
- 1999-06-09 HU HU9901911A patent/HU220894B1/hu not_active IP Right Cessation
- 1999-06-10 KR KR1019990021485A patent/KR100344732B1/ko not_active Expired - Fee Related
- 1999-06-10 AR ARP990102763A patent/AR019859A1/es active IP Right Grant
- 1999-06-10 YU YU26499A patent/YU26499A/sh unknown
- 1999-06-10 JP JP16357099A patent/JP3286268B2/ja not_active Expired - Fee Related
- 1999-06-10 MA MA25616A patent/MA26644A1/fr unknown
- 1999-06-10 AU AU34987/99A patent/AU743983B2/en not_active Ceased
- 1999-06-11 PL PL99333695A patent/PL333695A1/xx unknown
- 1999-06-11 CN CN99108373A patent/CN1107066C/zh not_active Expired - Fee Related
- 1999-06-11 NO NO19992873A patent/NO312590B1/no unknown
- 1999-06-11 BR BR9902651-1A patent/BR9902651A/pt not_active Application Discontinuation
- 1999-06-11 TR TR1999/01381A patent/TR199901381A3/tr unknown
- 1999-06-11 HR HR98110804.6A patent/HRP990188A2/hr not_active Application Discontinuation
- 1999-06-11 US US09/330,851 patent/US6113527A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9901911A1 (hu) | Orfanin FQ (OFQ) receptor agonista és/vagy antagonista diaza-spiro[3,5]nonán-származékok, előállításuk és alkalmazásuk | |
| HUP0302337A2 (hu) | Pirimidin-2,4,6-trion metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| ATE88182T1 (de) | Antidepressive n-substitierte nikotinamidverbindungen. | |
| MY119238A (en) | 8-quinolinzanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors | |
| AU2001272476A1 (en) | Piperidines for use as orexin receptor antagonists | |
| HUP9901256A2 (hu) | Benzoilszármazékok, eljárás az előállításukra, hatóanyagként ezeket tartalmazó gyomirtó készítmények és eljárás az alkalmazásukra | |
| CA2316902A1 (en) | Alpha-aminoamide derivatives useful as analgesic agents | |
| IE883453L (en) | Ergoline derivatives | |
| FI932904A0 (fi) | Foerfarande foer framstaellning av substituerade bensofuranderivat | |
| DK0458624T3 (da) | Fremgangsmåde til fremstilling af lactamderivater | |
| GR3003776T3 (hu) | ||
| HUP9901910A2 (hu) | Orfanin FQ(OFQ) receptor agonista és/vagy antagonista di- vagy tri-aza-spiro[4,5]dekán-származékok, előállításuk és alkalmazásuk | |
| DE3869163D1 (de) | Benzylidenamino-, benzylamino- und benzoylamino-imidazolderivate. | |
| ATE170851T1 (de) | Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten | |
| ATE172974T1 (de) | 3-oxadiazolyl-1,6-naphthyridinderivate mit affinität an die benzodiazepin-rezeptoren | |
| HUP9900883A2 (hu) | Helyettesített kinoxalin 2,3-dion származékok aminosav származékai, mint glutamát receptor antagonista vegyületek | |
| ES8701729A1 (es) | Procedimiento de preparacion de nuevos derivados de la 8-alcoxicarbonilamino-isoquinolina y de sus sales de adicion acida | |
| ATE151750T1 (de) | 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind | |
| BG106079A (en) | Cyclocarbamate derivatives as progesterone receptor modulators | |
| ES472407A1 (es) | Procedimiento para la preparacion de nuevos 2'-hidroxi-2-(5-isoxazolilmetil)-6,7-benzomorfanos. | |
| MY132049A (en) | Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |